Publication | Closed Access

Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen

VaccinationMedicineImmunologyAntigen ProcessingCd4 T Cell ResponsesFunctional AntibodiesVaccine DesignCellular Immune ResponseImmune SystemCd4+ T-cell ResponsesSynthetic ImmunologySynthetic Tlr4 Agonists